BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7995324)

  • 1. A pharmacokinetic interaction between roxithromycin and midazolam.
    Backman JT; Aranko K; Himberg JJ; Olkkola KT
    Eur J Clin Pharmacol; 1994; 46(6):551-5. PubMed ID: 7995324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral single doses of erythromycin and roxithromycin may increase the effects of midazolam on human performance.
    Mattila MJ; Idänpään-Heikkilä JJ; Törnwall M; Vanakoski J
    Pharmacol Toxicol; 1993 Sep; 73(3):180-5. PubMed ID: 8265524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potentially hazardous interaction between erythromycin and midazolam.
    Olkkola KT; Aranko K; Luurila H; Hiller A; Saarnivaara L; Himberg JJ; Neuvonen PJ
    Clin Pharmacol Ther; 1993 Mar; 53(3):298-305. PubMed ID: 8453848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin does not increase plasma concentrations of oral midazolam.
    Backman JT; Olkkola KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):356-9. PubMed ID: 7582388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of midazolam should be reduced during diltiazem and verapamil treatments.
    Backman JT; Olkkola KT; Aranko K; Himberg JJ; Neuvonen PJ
    Br J Clin Pharmacol; 1994 Mar; 37(3):221-5. PubMed ID: 8198928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.
    Olkkola KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 1994 May; 55(5):481-5. PubMed ID: 8181191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin drastically reduces plasma concentrations and effects of oral midazolam.
    Backman JT; Olkkola KT; Neuvonen PJ
    Clin Pharmacol Ther; 1996 Jan; 59(1):7-13. PubMed ID: 8549036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Br J Clin Pharmacol; 1995 Sep; 40(3):270-2. PubMed ID: 8527290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects.
    Wong SL; Goldberg MR; Ballow CH; Kitt MM; Barriere SL
    Pharmacotherapy; 2010 Feb; 30(2):136-43. PubMed ID: 20099988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between erythromycin and nitrazepam in healthy volunteers.
    Luurila H; Olkkola KT; Neuvonen PJ
    Pharmacol Toxicol; 1995 Apr; 76(4):255-8. PubMed ID: 7617555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of pharmacokinetic interaction of paroxetine and roxithromycin on bencycloquidium bromide in healthy subjects.
    Agbokponto JE; Luo Z; Liu R; Liu Z; Liang M; Ding L
    Eur J Pharm Sci; 2015 Mar; 69():37-43. PubMed ID: 25559065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of roxithromycin on the pharmacokinetics of lovastatin in volunteers.
    Bucher M; Mair G; Kees F
    Eur J Clin Pharmacol; 2002 Jan; 57(11):787-91. PubMed ID: 11868800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Olkkola KT; Ahonen J; Neuvonen PJ
    Anesth Analg; 1996 Mar; 82(3):511-6. PubMed ID: 8623953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.
    Ahonen J; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1997; 51(5):415-9. PubMed ID: 9049584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between midazolam and clarithromycin: comparison with azithromycin.
    Yeates RA; Laufen H; Zimmermann T
    Int J Clin Pharmacol Ther; 1996 Sep; 34(9):400-5. PubMed ID: 8880291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
    Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
    Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction of erythromycin with temazepam.
    Luurila H; Olkkola KT; Neuvonen PJ
    Ther Drug Monit; 1994 Dec; 16(6):548-51. PubMed ID: 7878692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metronidazole on midazolam metabolism in vitro and in vivo.
    Wang JS; Backman JT; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 2000 Nov; 56(8):555-9. PubMed ID: 11151744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.